Further, this correlation was found along with a downregulation of PSA levels, suggesting an important need for the inclusion of other biomarkers in the PCa diagnosis, given the possible occurrence of a faulty diagnosis [16]. The gene discussed is KLK3; the disease is posterior cortical atrophy.